BenevolentAI
investing in a premium platform at an attractive valuation tech approach knowledge graph mechanism mapping high throughput imaging protein motion simulations physics based based drug design in house clinical pipeline in house platform derived in clinic big discovery collaborations market cap | BenevolentAI
Company
Deck Type
Deck date
December 2021
Slide
39 of 42
Related slides by other companies
Investor Presentation
March 2024
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Day
June 2022
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io